PERSPECTA

News from every angle

← Back to headlines

Novartis Misses Q1 Earnings Estimates Amid Generic Competition

Novartis reported first-quarter earnings that fell short of sales and profit estimates, primarily due to the impact of generic competition on its drug Entresto. Despite the miss, the company reaffirmed its growth outlook for 2026.

28 Apr, 09:27 — 28 Apr, 09:27
PostShare

Sources

Showing 1 of 2 sources
seeking-alphaMixed1d ago

Novartis slips as U.S. generic erosion weighs on Q1 results

Read full article →

Coverage Timeline

First report: Reuters · 28 Apr, 05:12Full coverage: 2 · 4hWindow: 4h
Left-leaningCenterRight-leaning
Reuters28 Apr, 05:12First to report

Novartis misses quarterly sales, profit estimates as Entresto generics hit growth - Reuters

4h later
seeking-alpha28 Apr, 09:27Latest update

Novartis slips as U.S. generic erosion weighs on Q1 results

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Philippines Labor Department to Decide on Metro Manila Minimum Wage Hike

just now

Philippine Government Condonates Farmers' Debts in Eastern Visayas

just now

Philippines Braces for Fuel Price Hikes

just now